• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZIMVIE US CORP LLC TSX IMPLANT, 4.1MMD, 11.5MML; DENTAL IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZIMVIE US CORP LLC TSX IMPLANT, 4.1MMD, 11.5MML; DENTAL IMPLANT Back to Search Results
Catalog Number TSX41B11
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Unspecified Infection (1930); Inflammation (1932); Osteolysis (2377)
Date of Event 08/28/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Zimvie complaint number (b)(40.A4: patient weight unknown / not provided.D10.Concomitant medical products.Tsx41b13, tsx implant, 4.1mmd, 13mml lot 1271375.Tsx41b11, tsx implant, 4.1mmd, 11.5mml lot 1269508.Tsx37b11, tsx implant, 3.7mmd, 11.5mml lot 1271716.E1: reporter email address unknown / not provided.H6: event problem codes ¿ patient code: 1994 pain.A summary investigation has been completed for peri-implantitis events recognizing that a definitive root cause cannot be identified due to a wide range of external factors (non-design or manufacturing related), including medical conditions (e.G., diabetes, poor bone quality, etc.) / patient habits (e.G., smoking) and surgical technique.Previously completed investigations for these events have not identified any signals indicating potential non-conformances affecting the manufacturing and sterilization processes.Furthermore, the probability of a manufacturing or design defect that might lead to peri-implantitis occurring and escaping the available detections has been assessed and found remote and almost nonexistent.Should additional information be received which indicates that the device may have caused or contributed to the event, an additional report will be submitted.
 
Event or Problem Description
It was reported that the implants at tooth site # 12,22,14, 24 were removed due to a peri-implantitis.Patient suffered from pain and inflammation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TSX IMPLANT, 4.1MMD, 11.5MML
Common Device Name
DENTAL IMPLANT
Manufacturer (Section D)
ZIMVIE US CORP LLC
4555 riverside drive
palm beach gardens FL 33410
Manufacturer (Section G)
ZIMVIE US CORP LLC
4555 riverside drive
palm beach gardens FL 33410
Manufacturer Contact
mark mashburn
4555 riverside drive
palm beach gardens, FL 33410
5619713230
MDR Report Key24597645
Report Number0001038806-2026-01365
Device Sequence Number15843099
Product Code DZE
UDI-Device Identifier00844868045106
UDI-Public(01)00844868045106(17)250713(10)1269508
Combination Product (Y/N)N
Initial Reporter CountryFR
PMA/510(K) Number
K220978
Exemption Number5645646
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Device Explanted Year2025
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional
Initial Reporter Occupation Dentist
Type of Report Initial
Report Date (Section B) 03/13/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Expiration Date07/13/2025
Device Catalogue NumberTSX41B11
Device Lot Number1269508
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/24/2026
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date03/13/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured07/14/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
DENTAL IMPLANT
Outcome Attributed to Adverse Event Required Intervention;
Patient Age55 YR
Patient SexFemale
Patient EthnicityNon Hispanic
-
-